New Juvenile Arthritis Studies Reaffirm Safety And Effectiveness Of Two Drugs

Two studies released reaffirmed TNF inhibitors, biologic agents often used to treat adults with rheumatoid arthritis, are safe and effective treatments for children with juvenile arthritis (JA). The two drugs, adalimumab and etanercept, were studied separately. One study focused solely on the effectiveness of adalimumab in children and the other focused on the safety of etanercept when used to treat children. Both studies highlighted promising results. [click link for full article]

More: continued here

Filed under: Arthritis on November 11th, 2007